1

Iran experiences in providing access and management of medicine at the time of war and sanctions

Prof. Mostafa Ghanei, Director General of Biotechnology Development Council (BDC)

7th World Health Summit Meeting2019

Prof. Mostafa Ghanei. Internist PulmonologistBaqiyatallah University of Medical Sciences

Pharmaceutical Industry Strategies: Past - Present

Past 1946

Dr. AbidiLaboratory Establishment

1958

Tolid DarouCompanyEstablishment

1963

Darou PakhshCompanyEstablishment

1964

PfizerCompany BranchEstablishment

1967

CyanamidCompany BranchEstablishment

1979

Islamic Revolution

1980

Iraq-IranImposed War

1981

Compilation of National Drug List

1988

Privatization ofPharmaceuticalIndustry

2003

NationalPharmaceuticalPolicy Compilation

2015

NationalPharmaceutical Policies Revision

present

BiotechnologyProducts Export toDifferent Countries

Pre Pre Post Post

Sales Trend of the Top Five Therapeutic Chemical Groups

5

Availability Trends of Cancer Drugs: Sanctions

6

Policies and Strategies

Co-operation with the Food and Drug Administration infacilitating joint venture between producing companies

Policy making to reduce the cost of production in the country

Encouraging export-centered companies

Guiding tax exemptions of knowledge-based companies tothe research, innovation, and exporting sectors ofcompanies

7

Iran’s Pharmaceutical Industry at a Glance

Generic and Brand-Generic Systems

More than 15000

Pharmacists

More than 186 Trading Companies

About 36 Distributing Companies

More than 107 Manufacturing

Companies

National self-sufficiency at 96% FP and

50% API

Possessing Higher than 9

billion USD Drug Economy

Strict Qualitative and Quantitative Controls on the Pharmaceutical

Industry

Possessing "National Drug

Policy“ more than Two Decades

8

Iran Position in Biotechnology Drugs

• Total No. of biotechnology Drugs developed in world : 160

• Total No. of biotechnology Drugs produced in Iran : 22

• Iran’s position in Asia: 2nd

9

Biotechnology Drugs Producing Countries in Asia

No. of Produced Drugs in Asia

Japan 31Iran 22India 12

South Korea 10China 10

10